This inventor holds 6 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Fochon Pharmaceuticals, Ltd., Shanghai Fochon Pharmaceutical Co., Ltd., Chongqing Fochon Pharmaceutical Co., Ltd.. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 7 
2 out of 13 
1 out of 3 Years Active: 2018-2025
Title: Huajie Zhang: Innovator in Pharmaceutical Sciences
Introduction
Huajie Zhang is a prominent inventor based in Chongqing, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative therapeutic agents. With a total of 6 patents to his name, Zhang's work has the potential to impact various medical treatments.
Latest Patents
Among his latest patents are groundbreaking inventions such as apoptosis-inducing agents, which include specific Bcl-2 inhibitors, pharmaceutical compositions, and methods of use. Additionally, he has developed macrocyclic compounds that serve as TRK kinase inhibitors, providing new avenues for pharmaceutical compositions and their applications.
Career Highlights
Zhang has worked with notable companies in the pharmaceutical industry, including Fochon Pharmaceuticals, Ltd. and Shanghai Fochon Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his expertise and contribute to the advancement of medical science.
Collaborations
Throughout his career, Zhang has collaborated with esteemed colleagues, including Xingdong Zhao and Haohan Tan. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Huajie Zhang's contributions to pharmaceutical sciences through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile